title: Lyme disease vaccination: safety first.
authors.affiliation: International Lyme and Associated Diseases Society, PO Box 341461, Bethesda, MD 20827-1461, USA. Electronic address: rstricker@usmamed.com.
authors.forename: Raphael B
authors.initials: RB
authors.lastname: Stricker
authors.affiliation: International Lyme and Associated Diseases Society, PO Box 341461, Bethesda, MD 20827-1461, USA.
authors.forename: Lorraine
authors.initials: L
authors.lastname: Johnson
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000954:Antigens, Surface / Q000009:adverse effects* / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000009:adverse effects* / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects* / Q000276:immunology*; D025065:Borrelia burgdorferi / Q000276:immunology*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000009:adverse effects* / Q000276:immunology*; D022123:Lyme Disease Vaccines / Q000009:adverse effects* / Q000276:immunology*; D008297:Male
chemical_list: D000276:Adjuvants, Immunologic; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; D022123:Lyme Disease Vaccines